403 Results for "

145

" in MedChemExpress (MCE) Product Catalog:
Products (403)

403 Results for "145" in MCE Product Catalog:

146
146 Publications Verification
Cat. No.: HY-100545
CAS No.: 126150-97-8
Purity:  99.23%
BAPTA-AM is a well-known membrane permeable Ca 2+ chelator. BAPTA-AM inhibits hERG channels, hKv1.3 and hKv1.5 channels in HEK 293 cells with IC50s of 1.3 μM, 1.45 μM and 1.23 μM, respectively .
loading...
    loading...
109
109 Cited Publications
Cat. No.: HY-10231
CAS No.: 685898-44-6
Purity:  ≥98.0%
PX-478 is a multifunctional HIF-1α inhibitor with properties including radiosensitization, autophagy activation, and lipid accumulation inhibition. PX-478 also blocks hypoxia-induced VEGF production and regulates β-cell phenotypes under hypoxic conditions. PX-478 induces cell cycle arrest and DNA damage, restores autophagic function, reduces foam cell formation, and maintains glucose homeostasis. PX-478 is widely used in research on related diseases such as human tumors (e.g., prostate cancer), type 2 diabetes, and atherosclerosis .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-108360
CAS No.: 1945950-21-9
Purity:  99.06%
Research Areas:  

Cancer

PDD 00017273 is a potent inhibitor of Poly(ADP-ribose) Glycohydrolase (PARG), with an IC50 of 26 nM, and a KD of 1.45 nM .
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-B0185
CAS No.: 137-58-6
Synonyms: Lignocaine
Lidocaine (Lignocaine) inhibits sodium channels involving complex voltage and using dependence . Lidocaine decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-κB signaling pathways. Lidocaine is an amide derivative and has potential for the research of ventricular arrhythmia .
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-B0185A
CAS No.: 73-78-9
Synonyms: Lignocaine hydrochloride
Lidocaine hydrochloride (Lignocaine hydrochloride) inhibits sodium channels involving complex voltage and using dependence . Lidocaine hydrochloride decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-κB signaling pathways. Lidocaine hydrochloride is an amide derivative and a agent to treat ventricular arrhythmia and an effective tumor-inhibitor .
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-B0185B
CAS No.: 6108-05-0
Synonyms: Lignocaine hydrochloride hydrate
Lidocaine (Lignocaine) hydrochloride hydrate inhibits sodium channels involving complex voltage and using dependence. Lidocaine hydrochloride hydrate decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-κB signaling pathways. Lidocaine hydrochloride hydrate is an amide derivative and has potential for the research of ventricular arrhythmia .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-17044
CAS No.: 1201438-56-3
Synonyms: IPI-145; INK1197
Target:  

PI3K

Research Areas:  

Cancer

Duvelisib (IPI-145) is a selectivite p100δ inhibitor with IC50 of 2.5 nM, 27.4 nM, 85 nM and 1602 nM for p110δ, P110γ, p110β and p110α, respectively .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-N0083
CAS No.: 473-98-3
Synonyms: Trochol
Betulin (Trochol), is a sterol regulatory element-binding protein (SREBP) inhibitor with an IC50 of 14.5 μM in K562 cell line .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-P7066
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rMubFGF; HBGF-2; FGF-2; FGF-b; FGF-basic
Species:  
Source:  
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-117043
CAS No.: 1093070-16-6
Purity:  99.62%
Target:  

Deubiquitinase SARS-CoV

Research Areas:  

Infection

GRL0617 is a selective and competitive noncovalent inhibitor of severe acute respiratory syndrome (SARS-CoV) papain-like protease (PLpro), with an IC50 of 0.6 μM and a Ki value of 0.49 μM. GRL0617 also inhibits SARS-CoV with an EC50 of 14.5 μM. GRL0617 can be used for the research of severe acute respiratory syndrome .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-101507
CAS No.: 1628287-16-0
Purity:  99.47%
Synonyms: Pico145; HC-608
Target:  

TRP Channel

Research Areas:  

Cancer

Pico145 (HC-608) is a remarkable inhibitor of TRPC1/4/5 channels, inhibits (-)-englerin A-activated TRPC4/TRPC5 channels, with IC50s of 0.349 and 1.3 nM in cells, and shows no effect on TRPC3, TRPC6, TRPV1, TRPV4, TRPA1, TRPM2, TRPM8 .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-103312
CAS No.: 88903-69-9
Purity:  ≥99.0%
Synonyms: (-)-Xestospongin C
Xestospongin C ((-)-Xestospongin C) is a selective, reversible inositol 1,4,5-trisphosphate receptor (IP3R) inhibitor. Xestospongin C acts as an inhibitor of the sarcoplasmic/endoplasmic reticulum Ca 2+ ATPase (SERCA) pump of internal stores. Xestospongin C blocks IP3-induced Ca 2+ release from cerebellar microsomes with an IC50 of 358 nM. Xestospongin C is a valuable tool for investigating the structure and function of IP3Rs and Ca 2+ signaling in neuronal and nonneuronal cells .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-N6771
CAS No.: 18172-33-3
Cyclopiazonic acid is an endoplasmic reticulum calcium ATPase (ECAs) inhibitor and human respiratory syncytial virus (RSV) inhibitor (EC50 value of 4.13 μ M), which can reduce the antagonistic effect of 5-HT receptors in rat thoracic aorta, induce p53 dependent cell apoptosis and reproductive toxicity in mouse testes, and inhibit the biological activation of aflatoxin B [1][4][5].
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15779A
CAS No.: 1449240-68-9
Purity:  99.62%
Target:  

SphK Apoptosis

Research Areas:  

Cancer

K145 hydrochloride is a selective, substrate-competitive and orally active SphK2 inhibitor with an IC50 of 4.3 μM and a Ki of 6.4 μM. K145 hydrochloride is inactive against SphK1 and other protein kinases. K145 hydrochloride induces cell apoptosis and has potently antitumor activity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P990545
CAS No.: 2065212-40-8
Synonyms: ANX005

Target:  

Complement System

Research Areas:  

Neurological Disease

Tanruprubart (ANX005) is a C1q inhibitor and C1q depleter. Tanruprubart is a human antibody expressed in CHO cells, with huIgG1 heavy chains and huκ light chains, and its predicted molecular weight (MW) is 145 kDa. For the isotype control of Tanruprubart, refer to Human IgG4 kappa, Isotype Control (HY-P99003). The IC50 of Tanruprubart is 346 ng/mL for humans and 259 ng/mL for rats; its EC50 is 3.8 ng/mL for humans, 5.2 ng/mL for rats, and 9.9 ng/mL for mice. Tanruprubart is applicable to the research of Guillain-Barré syndrome and Alzheimer's disease .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15755
CAS No.: 1342278-01-6
Purity:  98.29%
Target:  

ROCK

Research Areas:  

Cancer

RKI-1447 is a potent small molecule inhibitor of ROCK1 and ROCK2 with IC50 values of 14.5 nM and 6.2 nM, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P7330
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHubFGF, 145a.a.; bFGF; FGF-2; HBGF-2; FGFB
Species:  
Source:  
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-139319
CAS No.: 227010-33-5
Purity:  99.88%
Target:  

Lactate Dehydrogenase

Research Areas:  

Cancer

LDHA-IN-3 (compound 2), as a selenobenzene compound, is a potent, noncompetitive lactate dehydrogenase (LDHA) inhibitor (IC50=145.2 nM). LDHA-IN-3 can be used for the research of cancer .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-110339
CAS No.: 1782109-09-4
Purity:  98.01%
Target:  

ROCK Apoptosis

Research Areas:  

Cancer

RKI 1447 dihydrochloride is a potent and selective ROCK inhibitor with IC50s of 14.5 and 6.2 nM for ROCK1 and ROCK2, respectively . RKI 1447 dihydrochloride suppresses colorectal carcinoma cell growth and promotes apoptosis .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P9930
CAS No.: 1256937-27-5
Synonyms: AMG 145
Evolocumab (AMG 145) is a human monoclonal antibody that inhibits PCSK9. Evolocumab is used in the study of hypercholesterolemia and atherosclerotic cardiovascular disease. Evolocumab binds to circulating PCSK9 protein and inhibits its binding to LDLR. Evolocumab has antioxidant and cytoprotective activities against H2O2-induced oxidative damage to endothelial cells. Evolocumab may also negatively regulate activation of the TLR-4/NF-κB signaling pathway to prevent inflammation .
loading...
    loading...